NAPSA-CLCN3 Fusion FISH Probe
The NAPSA-CLCN3 Fusion FISH Probe is used to confirm a fusion of the NAPSA and CLCN3 genes. The fusion of the NAPSA and CLCN3 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NAPSA-CLCN3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NAPSA-CLCN3-20-AQAQ | 20 (40 μL) | 200 μL |
|
CLCN3 Gene Summary
This gene encodes a member of the voltage-gated chloride channel (ClC) family. The encoded protein is present in all cell types and localized in plasma membranes and in intracellular vesicles. It is a multi-pass membrane protein which contains a ClC domain and two additional C-terminal CBS (cystathionine beta-synthase) domains. The ClC domain catalyzes the selective flow of Cl- ions across cell membranes, and the CBS domain may have a regulatory function. This protein plays a role in both acidification and transmitter loading of GABAergic synaptic vesicles, and in smooth muscle cell activation and neointima formation. This protein is required for lysophosphatidic acid (LPA)-activated Cl- current activity and fibroblast-to-myofibroblast differentiation. The protein activity is regulated by Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in glioma cells. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]
Gene Name: Chloride Voltage-gated Channel 3
Chromosome: CHR4: 170541671 -170644338
Locus: 4q33
NAPSA Gene Summary
This gene encodes a member of the peptidase A1 family of aspartic proteases. The encoded preproprotein is proteolytically processed to generate an activation peptide and the mature protease. The activation peptides of aspartic proteinases function as inhibitors of the protease active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The encoded protease may play a role in the proteolytic processing of pulmonary surfactant protein B in the lung and may function in protein catabolism in the renal proximal tubules. This gene has been described as a marker for lung adenocarcinoma and renal cell carcinoma. [provided by RefSeq, Feb 2016]
Gene Name: Napsin A Aspartic Peptidase
Chromosome: CHR19: 50861733 -50868931
Locus: 19q13.33
Gene Diseases
The NAPSA CLCN3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|